What is Eribulin Mesylate 0.5mg Ebunat Injection?
Eribulin Mesylate 0.5mg Ebunat Injection is used in the treatment of breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already taken other anticancer drugs after the cancer has spread.
How Trazumab Trastuzumab 440mg Injection is used?
Eribulin Mesylate 0.5mg Ebunat Injection can be used on its own, or sometimes given together with certain additional drugs as part of combination chemotherapy. It is given as injection under the supervision of doctor. Your doctor will decide what dose is essential and how often you need to take it. This will depend on what you are being treated for and may alter from time to time. You should take it exactly as your doctor has suggested. Ingesting it in the wrong way or taking too much can have very dangerous negative effects. It may take several weeks or months for you to see or feel the advantages but do not stop taking it until your doctor instructs you to.
How effective is eribulin?
Remarkably, relevant CNS effectiveness was demonstrated with eribulin: 20 percent of patients got partial response and 25 percent SD. Treatment was generally well tolerated and tolerable, with 29 percent grade 3 and 10.9 percent grade 4 toxicities. Median PFS and OS were 4.1 months (CI95 percent 3.2–4.9) and 11.1 months (CI95 percent 9.5–14.7), respectively.
How long can you stay on eribulin?
Each HALAVEN dose is delivered during a short period of 2 to 5 minutes. One cycle of treatment lasts 21 days, and consists of 1 IV infusion once a week for 2 weeks, and then 1 week without HALAVEN. It is possible that there may be a reason your health care practitioner may postpone or lower your dose or discontinue treatment.
What are the side effects of eribulin?
lack of appetite
changes in taste
weariness or weakness may occur.
If any of these symptoms persist or worsen, inform your doctor soon. Temporary hair loss may occur.
If you are looking for another product or brand click on docetec.